Epidermal growth factor receptor (EGFR); Lactobacillus rhamnosus GG p40 surface antigen (p40) BriefCommunication Pages: 658 - 658
Mice with limited apoptosis of specific cell types to model degenerative diseases BriefCommunication Pages: 667 - 667
Mouse models of low-density lipoprotein receptor–related protein 5 (LRP5)-driven regulation of bone mass BriefCommunication Pages: 668 - 668
Cultured, allogeneic Treg cells for preventing transplant rejection BriefCommunication Pages: 669 - 669
Cultured Treg cells for treating graft-versus-host-disease (GvHD) BriefCommunication Pages: 670 - 670
Embryonic stem cell (ESC)-derived midbrain dopaminergic neuronal progenitor cells for treating neurodegenerative diseases BriefCommunication Pages: 671 - 671
Expanding Treg cell counts with phosphodiesterase-3 (PDE-3) inhibitors BriefCommunication Pages: 672 - 672